Surgery Partners, Inc. (SGRY)

Surgery Partners Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	3,173	3,114	2,743	2,539	2,225	1,860
Revenue Growth (YoY)	13.54%	13.52%	8.03%	14.12%	19.62%	1.57%
Cost of Revenue	2,421	2,369	2,096	1,964	1,734	1,480
Gross Profit	752.2	745.6	647.5	574.9	491.4	379.8
Selling, General & Admin	141.5	138.7	120.9	102.2	104	97.1
Other Operating Expenses	-18	-20	-7.5	-19	-15.5	-1.7
Operating Expenses	278.7	271.3	231.5	198	187.3	190.2
Operating Income	473.5	474.3	416	376.9	304.1	189.6
Interest Expense	-216.6	-201.7	-193	-234.9	-221	-201.8
Earnings From Equity Investments	22.4	19.5	14.2	12.5	11.3	10.8
EBT Excluding Unusual Items	279.3	292.1	237.2	154.5	94.4	-1.4
Merger & Restructuring Charges	-107.4	-100.1	-61.7	-47.5	-39.8	-23.2
Impairment of Goodwill	-	-	-	-	-	-33.5
Gain (Loss) on Sale of Assets	-45.5	-40.6	-14.4	-11.1	-2.2	-5.7
Legal Settlements	-3.2	0.8	-10.6	29.3	-	-1.2
Other Unusual Items	-5.1	-5.1	-15.5	-14.9	28.8	46.2
Pretax Income	118.1	147.1	135	110.3	81.2	-18.8
Income Tax Expense	130.2	134.6	-0.3	23.3	10.5	-20.1
Earnings From Continuing Operations	-12.1	12.5	135.3	87	70.7	1.3
Minority Interest in Earnings	-181.3	-180.6	-147.2	-141.6	-141.6	-117.4
Net Income	-193.4	-168.1	-11.9	-54.6	-70.9	-116.1
Preferred Dividends & Other Adjustments	-	-	-	-	10.3	39.5
Net Income to Common	-193.4	-168.1	-11.9	-54.6	-81.2	-155.6
Shares Outstanding (Basic)	126	126	126	92	72	49
Shares Outstanding (Diluted)	126	126	126	92	72	49
Shares Change (YoY)	0.38%	0.40%	36.61%	26.96%	48.49%	1.03%
EPS (Basic)	-1.53	-1.33	-0.09	-0.59	-1.12	-3.19
EPS (Diluted)	-1.53	-1.33	-0.09	-0.59	-1.12	-3.19
Free Cash Flow	173.3	209.7	205	78.2	29.5	204
Free Cash Flow Per Share	1.37	1.66	1.63	0.85	0.41	4.18
Gross Margin	23.71%	23.94%	23.60%	22.64%	22.08%	20.42%
Operating Margin	14.92%	15.23%	15.16%	14.84%	13.67%	10.19%
Profit Margin	-6.09%	-5.40%	-0.43%	-2.15%	-3.65%	-8.37%
Free Cash Flow Margin	5.46%	6.73%	7.47%	3.08%	1.33%	10.97%
EBITDA	628.7	626.9	534.1	491.7	402.9	284.4
EBITDA Margin	19.81%	20.13%	19.47%	19.36%	18.11%	15.29%
D&A For EBITDA	155.2	152.6	118.1	114.8	98.8	94.8
EBIT	473.5	474.3	416	376.9	304.1	189.6
EBIT Margin	14.92%	15.23%	15.16%	14.84%	13.67%	10.19%
Effective Tax Rate	110.25%	91.50%	-	21.12%	12.93%	-

Updated May 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q